4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. (FDMT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FDMT · as of Jun 8, 2026
Key Statistics
Explore 4D Molecular Therapeutics, Inc. Data
fdmt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 71.4%
The FDMT analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $33.00, representing +281.94% upside from the current price of $8.64.
Competitors & Peers
fdmt competitorsFDMT
ADCT
BCYC
CMPX
GOSS
KALVStock Performance
Full HistoryAbout 4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidat…
what is 4d molecular therapeutics, inc. · fdmt stock overview · 4d molecular therapeutics, inc. company profile · who is 4d molecular therapeutics, inc. ceo · fdmt NASDAQ · 4d molecular therapeutics, inc. headquarters · 4d molecular therapeutics, inc. business segments
About Stock Overview & Key Data
4D Molecular Therapeutics, Inc. (FDMT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 11, 2020. As of the latest trading session, FDMT stock price is $8.64, with a market capitalization of $451.7M. The stock has returned +80.38% over the past 12 months and +15.20% year-to-date.
According to 14 Wall Street analysts, the consensus rating for 4D Molecular Therapeutics, Inc. stock is Buy, with an average 12-month price target of $33.00. In fiscal year 2025, 4D Molecular Therapeutics, Inc. reported revenue of $85.2M and net income of -$140.1M. For detailed data — including 4D Molecular Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, 4D Molecular Therapeutics, Inc. (FDMT) stock price is $8.64. The stock is traded on NASDAQ under the ticker symbol FDMT. The 52-week range is $3.68 – $12.34.